Cargando…
Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
Autores principales: | DiNicolantonio, James J, O’Keefe, James H, McCarty, Mark F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589004/ https://www.ncbi.nlm.nih.gov/pubmed/28912955 http://dx.doi.org/10.1136/openhrt-2017-000642 |
Ejemplares similares
-
Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
por: DiNicolantonio, James J, et al.
Publicado: (2019) -
Nutraceutical activation of Sirt1: a review
por: DiNicolantonio, James J, et al.
Publicado: (2022) -
Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?
por: DiNicolantonio, James J, et al.
Publicado: (2017) -
Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress
por: McCarty, Mark F., et al.
Publicado: (2022) -
Decreased magnesium status may mediate the increased cardiovascular risk associated with calcium supplementation
por: DiNicolantonio, James J, et al.
Publicado: (2017)